tiprankstipranks
Trending News
More News >
111, Inc. (YI)
:YI
Advertisement

111 (YI) Price & Analysis

Compare
273 Followers

YI Stock Chart & Stats


111 News

YI FAQ

What was 111, Inc.’s price range in the past 12 months?
111, Inc. lowest stock price was $4.14 and its highest was $11.90 in the past 12 months.
    What is 111, Inc.’s market cap?
    111, Inc.’s market cap is $59.38M.
      When is 111, Inc.’s upcoming earnings report date?
      111, Inc.’s upcoming earnings report date is Aug 21, 2025 which is in 14 days.
        How were 111, Inc.’s earnings last quarter?
        111, Inc. released its earnings results on Jun 19, 2025. The company reported -$0.279 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.279.
          Is 111, Inc. overvalued?
          According to Wall Street analysts 111, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does 111, Inc. pay dividends?
            111, Inc. does not currently pay dividends.
            What is 111, Inc.’s EPS estimate?
            111, Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does 111, Inc. have?
            111, Inc. has 5,067,436 shares outstanding.
              What happened to 111, Inc.’s price movement after its last earnings report?
              111, Inc. reported an EPS of -$0.279 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.818%.
                Which hedge fund is a major shareholder of 111, Inc.?
                Currently, no hedge funds are holding shares in YI

                Company Description

                111, Inc.

                111, Inc., also known as YI, is a leading digital healthcare platform operating in China. The company specializes in providing online retail and wholesale of pharmaceuticals, health and wellness products, and medical services. Through its comprehensive e-commerce solutions, 111, Inc. connects consumers with an extensive range of pharmaceutical products, promoting accessibility and convenience in obtaining healthcare essentials.

                111 (YI) Earnings & Revenues

                YI Company Deck

                YI Earnings Call

                Q4 2025
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The earnings call demonstrates significant achievements in operational profitability and cost reduction despite challenging macroeconomic conditions and regulatory changes. The company's advancements in technology and supply chain expansion position it well for future growth, though market and competitive pressures remain.View all YI earnings summaries
                Similar Stocks
                Company
                Price & Change
                Follow
                Petmed Express
                Jasper Therapeutics
                Inozyme Pharma
                Akoya Biosciences
                Invivyd

                Ownership Overview

                0.06%0.51%99.43%
                Insiders
                0.51% Other Institutional Investors
                99.43% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis